Pro Share Advisors LLC Crinetics Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

$48.7 Billion
Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 22,040 shares of CRNX stock, worth $973,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,040

Previous 24,038 8.31%

Holding current value

$973,066

Previous $806,000 21.46%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$25.56 - $33.76 $51,068 - $67,452	-1,998 Reduced 8.31%	22,040 $633,000
Q1 2025 May 08, 2025	SELL	$32.3 - $53.15 $163,147 - $268,460	-5,051 Reduced 17.36%	24,038 $806,000
Q4 2024 Feb 13, 2025	BUY	$50.66 - $60.69 $489,122 - $585,961	9,655 Added 49.68%	29,089 $1.49 Million
Q3 2024 Nov 13, 2024	BUY	$43.83 - $54.98 $251,145 - $315,035	5,730 Added 41.81%	19,434 $992,000
Q2 2024 Aug 13, 2024	SELL	$42.12 - $51.91 $127,497 - $157,131	-3,027 Reduced 18.09%	13,704 $613,000
Q1 2024 May 08, 2024	BUY	$34.76 - $46.81 $57,527 - $77,470	1,655 Added 10.98%	16,731 $783,000
Q4 2023 Feb 14, 2024	BUY	$25.62 - $37.07 $79,550 - $115,102	3,105 Added 25.94%	15,076 $536,000
Q3 2023 Nov 13, 2023	BUY	$15.97 - $30.59 $24,593 - $47,108	1,540 Added 14.76%	11,971 $356,000
Q2 2023 Aug 10, 2023	BUY	$15.73 - $23.6 $164,079 - $246,171	10,431 New	10,431 $187,000
Q4 2022 Feb 02, 2023	BUY	$15.49 - $19.05 $14,142 - $17,392	913 Added 8.86%	11,222 $205,000
Q3 2022 Nov 04, 2022	BUY	$18.11 - $22.37 $4,165 - $5,145	230 Added 2.28%	10,309 $204,000
Q2 2022 Aug 01, 2022	SELL	$16.49 - $27.64 $57,385 - $96,187	-3,480 Reduced 25.67%	10,079 $188,000
Q1 2022 May 10, 2022	SELL	$17.15 - $28.31 $54,811 - $90,478	-3,196 Reduced 19.07%	13,559 $298,000
Q4 2021 Feb 08, 2022	BUY	$19.35 - $28.41 $72,001 - $105,713	3,721 Added 28.55%	16,755 $476,000
Q3 2021 Nov 12, 2021	SELL	$16.88 - $25.23 $53,729 - $80,307	-3,183 Reduced 19.63%	13,034 $274,000
Q2 2021 Aug 13, 2021	BUY	$15.9 - $21.15 $70,452 - $93,715	4,431 Added 37.6%	16,217 $306,000
Q1 2021 May 14, 2021	BUY	$13.3 - $17.55 $9,456 - $12,478	711 Added 6.42%	11,786 $180,000
Q4 2020 Feb 09, 2021	BUY	$12.08 - $17.46 $133,786 - $193,369	11,075 New	11,075 $156,000
Q2 2019 Aug 13, 2019	SELL	$21.48 - $27.71 $195,425 - $252,105	-9,098 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$21.07 - $29.31 $4,572 - $6,360	217 Added 2.44%	9,098 $207,000
Q4 2018 Feb 14, 2019	BUY	$22.4 - $35.39 $198,934 - $314,298	8,881 New	8,881 $266,000

Others Institutions Holding CRNX

# of Institutions

236

Shares Held

90M

Call Options Held

59.7K

Put Options Held

14.8K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.37B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Crinetics Pharmaceuticals, Inc. Transaction History